Management Blueprint Podcast: Simplify Complexity with Ben Larman

The complete word-for-word transcript of this episode is published by Summit OS on the canonical episode page. Out of respect for the publisher's editorial rights, we link out rather than mirror the full text here.

Read the full transcript: summitos.co/podcast/270-simplify-complexity-with-ben-larman

The publisher's page contains a speaker-attributed transcript covering: Larman's scientific background and motivation; the mechanics of antibody reactomics and DNA barcoding; how MIPSA enables self-assembling libraries; the Complex Data Delivery Framework for communicating high-dimensional output; AI's role in integrating reactome data with the scientific literature; and storytelling lessons for biotech founders.

Key quotes

"The immune system is incredibly complex. We're just scratching the surface in understanding it."

— H. Benjamin Larman, Infinity Bio

"There's roughly 100 trillion antibody molecules in every drop of blood storing information from prior immune responses."

— H. Benjamin Larman, Infinity Bio

"We use self-assembly in a single reaction allowing protein fragments to barcode themselves in one tube."

— H. Benjamin Larman, Infinity Bio

"You really need to understand your audience and how to tell your story to be heard."

— H. Benjamin Larman, Infinity Bio

"Telling the story is so important and building the team around that story is so important."

— H. Benjamin Larman, Infinity Bio

"When you drink your own Kool-Aid, you can oftentimes take that for granted."

— Steve Preda, host

Topics covered

• Larman's personal "why" and Infinity Bio's founding mission
• How reading the antibody reactome informs treatment of immune conditions
• The Antibody Reactomics Framework and its development
• DNA sequencing technology and its expanding role in healthcare
• Infinity Bio's unique approach using MIPSA technology
• The challenge of communicating complex data to non-specialist customers
• AI's role in transforming biomedical research
• Key questions biotech entrepreneurs should ask themselves

About the guest

H. Benjamin Larman, PhD, is Scientific Founder and Chief Scientific Officer of Infinity Bio and a faculty member at Johns Hopkins. His lab developed MIPSA and the broader reactomics methods that Infinity Bio now offers as a service to biopharma and academic partners. Connect on LinkedIn.

About the show

The Management Blueprint Podcast is hosted by Steve Preda of Summit OS. The show interviews founders and operators about the operating frameworks that let complex businesses scale. Episode 270 aired January 10, 2025.